Journal of Dual Diagnosis
Scope & Guideline
Advancing understanding of co-occurring disorders.
Introduction
Aims and Scopes
- Co-occurring Disorders Research:
The journal publishes studies on the prevalence, characteristics, and treatment of individuals suffering from both mental health disorders and substance use disorders, highlighting their interconnectedness. - Clinical Interventions and Treatment Strategies:
It focuses on evidence-based practices and innovative treatment approaches aimed at improving outcomes for patients with dual diagnoses, including pharmacological, psychological, and psychosocial interventions. - Impact of Trauma and Stress on Substance Use:
Research exploring the role of trauma, particularly post-traumatic stress disorder (PTSD), in the development and exacerbation of substance use disorders is a core area of focus. - Demographic and Sociocultural Influences:
The journal examines how various demographic factors, such as race, gender, and socioeconomic status, influence the manifestation and treatment of dual diagnosis, aiming to address health disparities. - Public Health Perspectives:
It contributes to the discourse on public health implications of dual diagnosis, including policy impacts and community health strategies, particularly in the context of emerging issues like the COVID-19 pandemic.
Trending and Emerging
- Impact of COVID-19 on Substance Use and Mental Health:
A significant number of recent studies have focused on how the COVID-19 pandemic has affected substance use patterns and mental health outcomes, showcasing the urgent need to adapt treatment and support mechanisms during public health crises. - Use of Technology in Treatment Delivery:
There is an increasing trend towards exploring digital interventions and telehealth solutions for managing dual diagnosis, indicating a shift towards modernizing treatment approaches to improve accessibility and engagement. - Understanding Trauma's Role in Dual Diagnosis:
Emerging research emphasizes the complexities of trauma in relation to substance use and mental health disorders, with a focus on tailored interventions addressing trauma-related symptoms. - Cultural and Racial Considerations in Treatment:
Recent publications have highlighted the importance of understanding cultural and racial factors in the treatment of dual diagnosis, striving for more inclusive and equitable healthcare practices. - Innovative Treatment Modalities:
The exploration of integrative treatment models, such as harm reduction and holistic approaches, is gaining traction, reflecting a broader acceptance of diverse strategies to address the multifaceted nature of dual diagnosis.
Declining or Waning
- Traditional Substance Use Treatment Models:
There appears to be a waning emphasis on conventional treatment models that do not integrate mental health services, as newer studies increasingly advocate for holistic, dual-focused approaches. - Single Disorder Studies:
Research focusing exclusively on either substance use disorders or mental health conditions, without considering their co-occurrence, is becoming less frequent, indicating a shift towards more integrated research frameworks. - Generalized Risk Factors without Contextual Analysis:
There is a decline in studies that discuss risk factors for substance use or mental health disorders in isolation, suggesting a preference for more nuanced analyses that consider the interplay of various factors in dual diagnosis. - Static Epidemiological Studies:
Epidemiological studies that do not address contemporary issues, such as the impact of recent societal changes or the pandemic on dual diagnosis, are less represented, indicating a need for more dynamic and contextually relevant research. - Focus on Non-Evidence-Based Interventions:
Research centered on interventions lacking rigorous evidence or those that do not demonstrate efficacy in dual diagnosis contexts is decreasing, as the journal prioritizes high-quality, evidence-based studies.
Similar Journals
Neuropsychopharmacology Reports
Fostering collaboration in the realm of mental health and pharmacology.Neuropsychopharmacology Reports is a leading open-access journal published by WILEY, dedicated to advancing the fields of clinical psychology, pharmacology, psychiatry, and mental health. Established in 2018, the journal aims to disseminate high-quality research findings, critical reviews, and innovative methodologies that elucidate the complexities of neuropsychopharmacology in enhancing mental health outcomes. With an impressive impact indicated by its Q2 rankings in several categories including Clinical Psychology and Pharmacology (medical) as of 2023, Neuropsychopharmacology Reports stands out as a vital resource for researchers, professionals, and students keen on exploring the interplay between pharmacological interventions and psychological well-being. The journal’s open-access nature ensures that critical advancements in this rapidly evolving field are readily available to a global audience, fostering collaboration and discourse among scholars and practitioners alike. Building on its indexed status with Scopus, the journal is positioned as a noteworthy contributor to ongoing discussions and developments in psychiatry and medical pharmacology.
ADDICTIVE BEHAVIORS
Decoding the Science Behind Addictive BehaviorsADDICTIVE BEHAVIORS is a prestigious journal published by PERGAMON-ELSEVIER SCIENCE LTD, specializing in the critical examination and exploration of addiction-related issues across diverse fields including Clinical Psychology, Psychiatry and Mental Health, and Toxicology. With a robust history dating back to 1975 and convergence extending to 2024, the journal is esteemed for its rigorous peer-reviewed research that contributes significantly to understanding addiction phenomena. Ranked in the Q1 category for its focus areas, it stands out within the academic community, evidenced by its impressive Scopus rankings—25th in Clinical Psychology and 14th in Toxicology—placing it in the top tier of its disciplines. This journal offers valuable insights into addiction behaviors, treatment methodologies, and public health implications, making it an essential resource for researchers, practitioners, and students seeking to advance their knowledge and impact the field. Although not Open Access, it provides vital access options for institutions and individuals invested in addiction studies.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
Uncovering the Complexities of Drug and Alcohol UseAmerican Journal of Drug and Alcohol Abuse is a highly regarded publication in the field of substance abuse research, published by Taylor & Francis Inc. With its inception in 1974, this journal has become an essential resource for scholars and practitioners interested in clinical psychology, psychiatry, and the multifaceted issues surrounding drug and alcohol use. It holds a notable Q2 ranking in Clinical Psychology, Medicine (miscellaneous), and Psychiatry and Mental Health, emphasizing its impact and relevance in these domains. The journal's 2023 Scopus rankings further highlight its standing, placing it in the top quartile of publications with established readership and citation metrics. Researchers and students can benefit from its comprehensive articles that delve into the complexities of substance use, treatment methodologies, and the socio-psychological underpinnings of addiction. Whether you seek to access cutting-edge studies or contribute to ongoing discourse in the field, the American Journal of Drug and Alcohol Abuse serves as a vital hub for knowledge dissemination and scholarly engagement.
Klinik Psikiyatri Dergisi-Turkish Journal of Clinical Psychiatry
Empowering Minds with Cutting-Edge Psychiatric ResearchKlinik Psikiyatri Dergisi - Turkish Journal of Clinical Psychiatry is a distinguished open-access journal dedicated to the evolving field of psychiatry and mental health. Published by KLINIK PSIKIYATRI DERGISI in Turkey since 1998, this journal aims to provide a platform for the dissemination of research, clinical studies, and reviews that contribute to the understanding of psychological disorders and treatment methodologies. With an ISSN of 1302-0099 and an E-ISSN of 2146-7153, the journal is indexed in various databases, although it currently holds a rank of 460/567 in the Scopus ranking for the category of Medicine: Psychiatry and Mental Health. The journal operates under an open-access model, ensuring that research findings are readily accessible to a wide audience, contributing to greater knowledge and awareness in the field. As it converges from 2017 to 2024, Klinik Psikiyatri Dergisi continues to strive for excellence, providing valuable insights and resources for researchers, professionals, and students interested in the complexities of mental health.
DRUG AND ALCOHOL REVIEW
Shaping policy through multidisciplinary insights.DRUG AND ALCOHOL REVIEW, published by Wiley, is a leading journal dedicated to advancing the scholarship in the fields of drug and alcohol research. Since its inception in 1989, this esteemed publication has provided a critical platform for the dissemination of innovative research findings, reviews, and theoretical papers, addressing pressing issues in substance use and addiction. With an impact factor that places it in the Q1 category in both Health (social science) and Medicine (miscellaneous), it ranks #78 out of 371 in the Scopus index for Health and #115 out of 398 in Medicine, reflecting its significant influence and high citation rates among scholars. The journal is committed to fostering a multidisciplinary approach, integrating perspectives from psychology, sociology, public health, and medicine, to inform policy and practice. Accessible to researchers and practitioners alike, *DRUG AND ALCOHOL REVIEW* serves as an essential resource for anyone invested in understanding and addressing the complexities of drug and alcohol use in society.
Annals of Clinical Psychiatry
Advancing the Frontiers of Clinical Psychiatry.Annals of Clinical Psychiatry, published by QUADRANT HEALTHCOM INC, is a leading journal in the fields of Medicine and Psychiatry & Mental Health. With its longstanding commitment to advancing clinical knowledge since 1989, this esteemed journal contributes invaluable insights into current psychiatric practices and mental health research. The journal is recognized in the Scopus ranking with a position in the 34th percentile, reflective of its focused scope and substantial academic contributions. While access to the journal is tailored for professionals and researchers, the absence of Open Access highlights the journal's dedication to maintaining quality and rigorous peer-reviewed standards. As part of the Q3 quartile for both Medicine and Psychiatry categories in 2023, Annals of Clinical Psychiatry serves as an essential resource for those dedicated to improving mental health outcomes, making it a vital platform for practitioners, researchers, and students alike. Situated in Parsippany, New Jersey, the journal remains a pivotal entity that fosters scholarly dialogue and exploration in clinical psychiatry.
Advances in Dual Diagnosis
Pioneering Research for Integrated Mental Health SolutionsAdvances in Dual Diagnosis, published by EMERALD GROUP PUBLISHING LTD, serves as a vital resource for professionals and researchers in the fields of psychiatry and mental health. With an ISSN of 1757-0972 and E-ISSN 2042-8324, this journal has been at the forefront of dual diagnosis research since its inception in 2008, aiming to bridge the gap in knowledge and practice regarding the co-occurrence of mental health disorders and substance use issues. Rated in the Q4 category for Psychiatry and Mental Health, it ranks 31st out of 45 in Nursing and Psychiatric Mental Health and 408th out of 567 in Medicine and Psychiatry, providing a unique platform for showcasing emerging research, innovative treatment strategies, and case studies that enhance understanding of complex patient needs. While the journal is not openly accessible, its contributions are crucial for driving forward the academic discourse and practical applications surrounding dual diagnosis. As we look to the future through 2024 and beyond, the Advances in Dual Diagnosis journal continues to strive for excellence in disseminating knowledge that benefits practitioners and scholars alike.
JOURNAL OF SUBSTANCE ABUSE TREATMENT
Empowering Research for Effective Recovery SolutionsJOURNAL OF SUBSTANCE ABUSE TREATMENT, published by Pergamon-Elsevier Science Ltd, is a leading peer-reviewed journal that spans a wide range of topics related to substance abuse and addiction treatments. With an impressive impact factor, this esteemed journal ranks in the Q1 quartile across multiple disciplines including Clinical Psychology, Medicine (miscellaneous), and Psychiatry and Mental Health, making it a vital resource for researchers and practitioners alike. Covering convergence years from 1984 to 2023, it publishes cutting-edge research that informs treatment methodologies and policy development in the field of substance abuse. With access options that adapt to both traditional and modern academic needs, the journal seeks to advance the understanding and effectiveness of substance abuse treatment through comprehensive studies and innovative approaches. Be part of a global dialogue that shapes the future of addiction treatment by engaging with the latest findings and expert analyses that help bridge the gap between research and clinical practice.
Canadian Journal of Addiction
Exploring the complexities of addiction research.Canadian Journal of Addiction is a leading platform dedicated to advancing the understanding of addiction and its multifaceted impacts on individuals and society. Published by LIPPINCOTT WILLIAMS & WILKINS, this journal aims to foster rigorous research and discussion in the field of addiction studies, contributing significantly to the intersection of psychiatry and mental health. With its ISSN 2368-4720 and E-ISSN 2368-4739, the journal is indexed in Scopus and has been categorized in the Q3 quartile for 2023, reflecting its emerging influence amongst peers. The Canadian Journal of Addiction facilitates a vital exchange of ideas and findings, crucial for researchers, practitioners, and students alike, addressing pressing issues related to addiction through innovative studies and insightful reviews. Subscribers and readers benefit from the latest findings as they navigate through the dynamic landscape of addiction research, enriching both academic knowledge and practical applications.
Rivista di Psichiatria
Navigating the Landscape of Mental Health UnderstandingRivista di Psichiatria, published by PENSIERO SCIENTIFICO EDITORE, stands as a significant contributor to the field of Psychiatry and Mental Health since its inception in 1975. With an ISSN of 0035-6484 and an E-ISSN of 2038-2502, this esteemed journal offers a platform for rigorous academic discourse and cutting-edge research, helping to shape contemporary psychiatric practices and theories. Currently holding a Q2 designation in Psychiatry and Mental Health based on the 2023 category quartiles, and ranking #197 out of 567 in Scopus, it reflects a commendable 65th percentile among its peers. The journal welcomes contributions that encompass a broad range of topics related to mental health, encouraging contributions from a multidisciplinary approach, which aids in its goal of advancing the understanding and application of psychiatric science. While it is a traditional journal without Open Access options, access to its valuable content can support researchers, clinicians, and students in their pursuit of knowledge and innovation within the field. Situated in Rome, Italy, at VIA SAN GIOVANNI VALDARNO 8, ROME 00138, the journal continues to enhance its rich legacy, promoting the exchange of ideas and fostering collaboration amongst practitioners and scholars alike.